Cargando…

Stroke in a Child with Hemoglobin SC Disease: A Case Report Describing use of Hydroxyurea after Transfusion Therapy

Children with hemoglobin SC (HbSC) disease suffer a significant incidence of silent cerebral infarcts but stroke is rare. A 2-year-old African American boy with HbSC disease presented with focal neurologic deficits associated with magnetic resonance imaging evidence of cerebral infarction with vascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fridlyand, Diana, Wilder, Caroline, Clay, E. Leila Jerome, Gilbert, Bruce, Pace, Betty S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379224/ https://www.ncbi.nlm.nih.gov/pubmed/28435652 http://dx.doi.org/10.4081/pr.2017.6984

Ejemplares similares

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision
por: Creary, Susan, et al.
Publicado: (2015)

P-075: HYDROXYUREA: EFFECTS ON TREATMENT OF CHILDREN WITH HEMOGLOBINOPATHY SC
por: A., CAMPOS, et al.
Publicado: (2022)

Most adults with severe HbSC disease are not treated with hydroxyurea
por: Ghunney, William Kwesi, et al.
Publicado: (2023)

Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia
por: Lebensburger, Jeffrey D, et al.
Publicado: (2015)

Blood Transfusion Vs. Hydroxyurea for Stroke Prevention in Children With Sickle Cell Anemia: A Systematic Review and Meta-Analysis
por: Hafiz, Tamara A, et al.
Publicado: (2022)

Candidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with Hydroxyurea
por: Green, Nancy S., et al.
Publicado: (2013)

TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, randomised controlled trial
por: Ware, Russell E., et al.
Publicado: (2015)

Efficacy of Hydroxyurea in Transfusion-Dependent Major β-Thalassemia Patients: A Meta-Analysis
por: Hatamleh, Modather I, et al.
Publicado: (2023)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

Hemoglobin SC smear recorded with a smartphone
por: Trikalinos, Nikolaos A., et al.
Publicado: (2016)

Enteric Fever Unmasking Hemoglobin SC Disease
por: Arango-Ferreira, Catalina, et al.
Publicado: (2021)

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
por: Nickel, Robert Sheppard, et al.
Publicado: (2020)

A Patient With Hemoglobin SC Disease and Acute Ischemic Stroke Presenting With Altered Mental Status
por: Thida, Aye M, et al.
Publicado: (2021)

Timing of Transfusion, not Hemoglobin Variability, Is Associated with 3-Month Outcomes in Acute Ischemic Stroke
por: Kim, Chulho, et al.
Publicado: (2020)

Using the MWC model to describe heterotropic interactions in hemoglobin
por: Rapp, Olga, et al.
Publicado: (2017)

Comparison of in-vitro and in-vivo response to fetal hemoglobin production and γ-mRNA expression by hydroxyurea in Hemoglobinopathies
por: Italia, Khushnooma, et al.
Publicado: (2013)

Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia
por: Sheehan, Vivien A., et al.
Publicado: (2014)

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia
por: Fitzhugh, Courtney D., et al.
Publicado: (2015)

HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes
por: Adegoke, Samuel Ademola, et al.
Publicado: (2022)

Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease
por: Darshana, Thamal, et al.
Publicado: (2021)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia
por: Yasara, Nirmani, et al.
Publicado: (2022)

Efficacy and Safety of Hydroxyurea as Adjuvant Therapy in Pediatric Patients of Transfusion-Dependent Beta-Thalassemia Major at Zhob, Balochistan
por: Akram, Sumera, et al.
Publicado: (2022)

Acute Chest Syndrome in Pregnant Women with Hemoglobin SC Disease
por: Nomura, Roseli Mieko Yamamoto, et al.
Publicado: (2009)

Massive Ovarian Edema in a Girl with Hemoglobin SC Disease
por: Johannesen, Eric, et al.
Publicado: (2018)

Debate: Transfusing to normal hemoglobin levels improves outcome
por: Haupt, Marilyn T
Publicado: (2001)

Impact of Storage Lesion on Post-transfusion Rise in Hemoglobin
por: Sardar, Muhammad, et al.
Publicado: (2018)

Hemoglobin Drop and the Need for Transfusion in Primary Knee Arthroplasty
por: Madan, Fatema H, et al.
Publicado: (2022)

Role of XmnI(G) Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients
por: Motovali-Bashi, Majid, et al.
Publicado: (2015)

O-01: HYDROXYUREA REDUCES THE TRANSFUSION BURDEN IN CHILDREN WITH SICKLE CELL ANEMIA IN SUB-SAHARAN AFRICA: THE REACH EXPERIENCE
por: A., POWER-HAYS, et al.
Publicado: (2022)

Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment
por: D’Alessandro, Angelo, et al.
Publicado: (2023)

Perioperative changes in hemoglobin levels during major hepatopancreatic surgery in transfused and non-transfused patients
por: Lammi, J.P., et al.
Publicado: (2020)

Loss of Penumbra by Impaired Oxygen Supply? Decreasing Hemoglobin Levels Predict Infarct Growth after Acute Ischemic Stroke: Stroke: Relevant Impact of Hemoglobin, Hematocrit and Transfusion (STRAIGHT) – An Observational Study
por: Kellert, L., et al.
Publicado: (2012)

Mobile Right Atrial Thrombi in a Patient with the Hemoglobin SC Disease
por: Savage, H. O., et al.
Publicado: (2011)

Unrecognized hemoglobin SC sickle cell disease complicated by sepsis and cholestasis
por: McFarland, Thomas, et al.
Publicado: (2022)

5588005 IMPACT OF COVID-19 PANDEMIC TO PRE-TRANSFUSION HEMOGLOBIN LEVEL AND FREQUENCY OF TRANSFUSION IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS IN INDONESIA
por: Dewi, M.K.D., et al.
Publicado: (2023)

P102: PLASMA FREE HEMOGLOBIN AND REACTIVE OXYGEN SPECIES IN SICKLE CELL ANAEMIA PATIENTS UNDER HYDROXYUREA AND GLUTAMINE THERAPY
por: Giannaki, A, et al.
Publicado: (2022)

P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
por: POWER-HAYS, A., et al.
Publicado: (2022)

Laboratory and Genetic Biomarkers Associated with Cerebral Blood Flow Velocity in Hemoglobin SC Disease
por: Santiago, Rayra Pereira, et al.
Publicado: (2017)

Hydroxyurea Induced Perimalleolar Ulcers
por: Saravu, Kavitha, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ujdu9v38rurkq4hcmr5j7h6jt4